GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Earnings per Share (Diluted)

Lombard Medical Technologies (LSE:LMT) Earnings per Share (Diluted) : £-0.20 (TTM As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Earnings per Share (Diluted)?

Lombard Medical Technologies's Earnings per Share (Diluted) for the six months ended in Dec. 2012 was £-0.20. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20.

Lombard Medical Technologies's EPS (Basic) for the six months ended in Dec. 2012 was £-0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20.

Lombard Medical Technologies's EPS without NRI for the six months ended in Dec. 2012 was £-0.20. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20.

During the past 3 years, the average EPS without NRIGrowth Rate was -21.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -46.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was -51.10% per year.

During the past 10 years, Lombard Medical Technologies's highest 3-Year average EPS without NRI Growth Rate was -3.10% per year. The lowest was -72.00% per year. And the median was -50.40% per year.


Lombard Medical Technologies Earnings per Share (Diluted) Historical Data

The historical data trend for Lombard Medical Technologies's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Earnings per Share (Diluted) Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.78 -1.59 -0.79 -0.62 -0.41

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.38 -0.58 -0.38 -0.27 -0.20

Competitive Comparison of Lombard Medical Technologies's Earnings per Share (Diluted)

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's PE Ratio falls into.



Lombard Medical Technologies Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Lombard Medical Technologies's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2012 is calculated as

Diluted Earnings Per Share (A: Dec. 2012 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-8.293-0)/20.162
=-0.41

Lombard Medical Technologies's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2012 is calculated as

Diluted Earnings Per Share (Q: Dec. 2012 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-8.293-0)/20.162
=-0.41

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Lombard Medical Technologies  (LSE:LMT) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Lombard Medical Technologies Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.